-
Signature
-
/s/ Chase Rosson by Power of Attorney
-
Stock symbol
-
ICHR
-
Transactions as of
-
Feb 14, 2025
-
Transactions value $
-
-$903,593
-
Form type
-
4
-
Date filed
-
2/19/2025, 05:33 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ICHR |
Ordinary Shares, par value $0.0001 |
Options Exercise |
$1.94M |
+78.1K |
+163.84% |
$24.89 |
126K |
Feb 14, 2025 |
Direct |
F1 |
transaction |
ICHR |
Ordinary Shares, par value $0.0001 |
Options Exercise |
$1.17M |
+46.9K |
+37.25% |
$24.89 |
173K |
Feb 14, 2025 |
Direct |
|
transaction |
ICHR |
Ordinary Shares, par value $0.0001 |
Sale |
-$2.5M |
-78.1K |
-45.24% |
$31.98 |
94.6K |
Feb 14, 2025 |
Direct |
F1 |
transaction |
ICHR |
Ordinary Shares, par value $0.0001 |
Sale |
-$1.52M |
-46.9K |
-49.57% |
$32.35 |
47.7K |
Feb 18, 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ICHR |
Option (right to buy) |
Options Exercise |
$0 |
-78.1K |
-62.5% |
$0.00 |
46.9K |
Feb 14, 2025 |
Ordinary Shares, par value $0.0001 |
78.1K |
$24.89 |
Direct |
F1, F2 |
transaction |
ICHR |
Option (right to buy) |
Options Exercise |
$0 |
-46.9K |
-100% |
$0.00 |
0 |
Feb 14, 2025 |
Ordinary Shares, par value $0.0001 |
46.9K |
$24.89 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: